Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination

Mass vaccination against coronavirus disease 2019 (COVID-19) is a global health strategy to control the COVID-19 pandemic. With the increasing number of vaccinations, COVID-19 vaccine-associated lymphadenopathy (C19-VAL) has been frequently reported. Current findings emphasize the characteristics of...

Full description

Bibliographic Details
Main Authors: Tzu-Chuan Ho, Daniel Hueng-Yuan Shen, Chin-Chuan Chang, Hung-Pin Chan, Kuo-Pin Chuang, Cheng-Hui Yuan, Ciao-Ning Chen, Ming-Hui Yang, Yu-Chang Tyan
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/3/696
_version_ 1797608730342195200
author Tzu-Chuan Ho
Daniel Hueng-Yuan Shen
Chin-Chuan Chang
Hung-Pin Chan
Kuo-Pin Chuang
Cheng-Hui Yuan
Ciao-Ning Chen
Ming-Hui Yang
Yu-Chang Tyan
author_facet Tzu-Chuan Ho
Daniel Hueng-Yuan Shen
Chin-Chuan Chang
Hung-Pin Chan
Kuo-Pin Chuang
Cheng-Hui Yuan
Ciao-Ning Chen
Ming-Hui Yang
Yu-Chang Tyan
author_sort Tzu-Chuan Ho
collection DOAJ
description Mass vaccination against coronavirus disease 2019 (COVID-19) is a global health strategy to control the COVID-19 pandemic. With the increasing number of vaccinations, COVID-19 vaccine-associated lymphadenopathy (C19-VAL) has been frequently reported. Current findings emphasize the characteristics of C19-VAL. The mechanism of C19-VAL is complicated to explore. Accumulated reports separately show that C19-VAL incidence is associated with receiver age and gender, reactive change within lymph nodes (LN), etc. We constructed a systematic review to evaluate the associated elements of C19-VAL and provide the mechanism of C19-VAL. Articles were searched from PubMed, Web of Science and EMBASE by using the processing of PRISMA. The search terms included combinations of the COVID-19 vaccine, COVID-19 vaccination and lymphadenopathy. Finally, sixty-two articles have been included in this study. Our results show that days post-vaccination and B cell germinal center response are negatively correlated with C19-VAL incidence. The reactive change within LN is highly related to C19-VAL development. The study results suggested that strong vaccine immune response may contribute to the C19-VAL development and perhaps through the B cell germinal center response post vaccination. From the perspective of imaging interpretation, it is important to carefully distinguish reactive lymph nodes from metastatic lymph node enlargement through medical history collection or evaluation, especially in patients with underlying malignancy.
first_indexed 2024-03-11T05:47:39Z
format Article
id doaj.art-f0ec17ab36b34bb4a8813ded7673b122
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-11T05:47:39Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-f0ec17ab36b34bb4a8813ded7673b1222023-11-17T14:19:43ZengMDPI AGVaccines2076-393X2023-03-0111369610.3390/vaccines11030696Immune Response Related to Lymphadenopathy Post COVID-19 VaccinationTzu-Chuan Ho0Daniel Hueng-Yuan Shen1Chin-Chuan Chang2Hung-Pin Chan3Kuo-Pin Chuang4Cheng-Hui Yuan5Ciao-Ning Chen6Ming-Hui Yang7Yu-Chang Tyan8Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 807, TaiwanDepartment of Nuclear Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, TaiwanDepartment of Nuclear Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, TaiwanDepartment of Nuclear Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, TaiwanGraduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 912, TaiwanMass Spectrometry Laboratory, Department of Chemistry, National University of Singapore, Singapore 119077, SingaporeDepartment of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 807, TaiwanDepartment of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 813, TaiwanDepartment of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 807, TaiwanMass vaccination against coronavirus disease 2019 (COVID-19) is a global health strategy to control the COVID-19 pandemic. With the increasing number of vaccinations, COVID-19 vaccine-associated lymphadenopathy (C19-VAL) has been frequently reported. Current findings emphasize the characteristics of C19-VAL. The mechanism of C19-VAL is complicated to explore. Accumulated reports separately show that C19-VAL incidence is associated with receiver age and gender, reactive change within lymph nodes (LN), etc. We constructed a systematic review to evaluate the associated elements of C19-VAL and provide the mechanism of C19-VAL. Articles were searched from PubMed, Web of Science and EMBASE by using the processing of PRISMA. The search terms included combinations of the COVID-19 vaccine, COVID-19 vaccination and lymphadenopathy. Finally, sixty-two articles have been included in this study. Our results show that days post-vaccination and B cell germinal center response are negatively correlated with C19-VAL incidence. The reactive change within LN is highly related to C19-VAL development. The study results suggested that strong vaccine immune response may contribute to the C19-VAL development and perhaps through the B cell germinal center response post vaccination. From the perspective of imaging interpretation, it is important to carefully distinguish reactive lymph nodes from metastatic lymph node enlargement through medical history collection or evaluation, especially in patients with underlying malignancy.https://www.mdpi.com/2076-393X/11/3/696COVID-19C19-VALlymphadenopathylymph node
spellingShingle Tzu-Chuan Ho
Daniel Hueng-Yuan Shen
Chin-Chuan Chang
Hung-Pin Chan
Kuo-Pin Chuang
Cheng-Hui Yuan
Ciao-Ning Chen
Ming-Hui Yang
Yu-Chang Tyan
Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination
Vaccines
COVID-19
C19-VAL
lymphadenopathy
lymph node
title Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination
title_full Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination
title_fullStr Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination
title_full_unstemmed Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination
title_short Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination
title_sort immune response related to lymphadenopathy post covid 19 vaccination
topic COVID-19
C19-VAL
lymphadenopathy
lymph node
url https://www.mdpi.com/2076-393X/11/3/696
work_keys_str_mv AT tzuchuanho immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT danielhuengyuanshen immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT chinchuanchang immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT hungpinchan immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT kuopinchuang immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT chenghuiyuan immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT ciaoningchen immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT minghuiyang immuneresponserelatedtolymphadenopathypostcovid19vaccination
AT yuchangtyan immuneresponserelatedtolymphadenopathypostcovid19vaccination